what does astrazeneca specialize in

AstraZeneca specializes in developing and manufacturing pharmaceutical products, with a focus on major therapeutic areas including oncology, cardiovascular, gastrointestinal, and respiratory diseases.

what does astrazeneca focus on

AstraZeneca focuses on research and development, particularly in oncology, cardiovascular, and respiratory diseases, as well as vaccines and biologics.

how does astrazeneca make money

AstraZeneca makes money through the sale of its pharmaceutical products, including prescription medicines, vaccines, and related services, primarily through partnerships with other companies.

how does astrazeneca sars-cov-2 vaccine work

AstraZeneca's SARS-CoV-2 vaccine works by using a viral vector technology that delivers a piece of the virus's genetic material into cells to trigger an immune response.

how does astrazeneca vaccine work

AstraZeneca's COVID-19 vaccine works by using a modified adenovirus to deliver the gene for the SARS-CoV-2 spike protein, prompting the body to produce antibodies against the virus.

AstraZeneca Pharma India Limited (ASTRAZEN) Share Price Today — ₹8,304.35

AstraZeneca Pharma India Limited (ASTRAZEN) live stock price is ₹8,304.35. Listed on BSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View AstraZeneca Pharma India Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for AstraZeneca Pharma India Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

ASTRAZEN

BSE

AstraZeneca Pharma India Limited

Healthcare· Pharmaceuticals & Biotechnology· INE203A01020· Scrip: 506820

EN हिन्दी ગુજરાતી मराठी

₹8,304.35

▲ 153.10 (+0.00%)

2026-06-10

BSE

₹8,304.35

▲ 153.10

+0.00%

233 trading days · 1Y period

TODAY (BSE)

Open8,470.10

High8,545.00

Low8,261.10

Prev Close8,457.45

Volume419

Value₹0.4Cr

L: 8,261.10H: 8,545.00

Info

Face Value₹2

Listed2001-05-04

ISININE203A01020

SeriesA

BSE Scrip506820

Key Metrics

1D

—

1W

—

1M

—

3M

—

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

Mkt Cap—

Growth (QoQ)

Revenue+7.92%

PAT-19.72%

EPS-19.71%

Profitability

EBITDA Margin14.2%

Net Margin7.0%

TTM EBITDA M.12.2%

TTM Net M.6.0%

Dividend

Yield—

Latest DPS₹32

Payout Ratio259.3%

Growth+33.33%

TTM Revenue

₹1619 Cr

TTM EBITDA

₹198 Cr

TTM PAT

₹97 Cr

TTM EPS

₹38.78

Rev/Share

₹647.6

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	440 Cr	373 Cr	63 Cr	42 Cr	31 Cr	₹12.34
2024-09-30	408 Cr	365 Cr	73 Cr	51 Cr	38 Cr	₹15.37
2024-06-30	388 Cr	353 Cr	-11 Cr	-15 Cr	-12 Cr	₹-4.72
2024-03-31	383 Cr	338 Cr	73 Cr	54 Cr	39 Cr	₹15.79
2023-12-31	306 Cr	295 Cr	29 Cr	20 Cr	16 Cr	₹6.32
2023-09-30	311 Cr	262 Cr	99 Cr	73 Cr	52 Cr	₹20.95
2023-06-30	295 Cr	232 Cr	75 Cr	71 Cr	54 Cr	₹21.54
2023-03-31	285 Cr	229 Cr	34 Cr	23 Cr	17 Cr	₹6.91

Shareholding Pattern

CURRENT — 2026-03-31

Promoter75.0%

FII2.8%

DII5.8%

Public25.0%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2025-07-18	Dividend	Dividend - Rs 32 Per Share
2024-07-05	Dividend	Dividend - Rs 24 Per Share
2023-07-14	Dividend	Dividend - Rs 16 Per Share
2022-07-07	Dividend	Dividend - Rs 8 Per Share
2021-08-18	Dividend	Interim Dividend - Rs 2 Per Share
2020-08-20	Dividend	Interim Dividend - Rs 2 Per Share
2019-08-20	Dividend	Interim Dividend - Re 1 Per Share
2018-08-30	Other	Annual General Meeting
2017-09-04	Other	Annual General Meeting
2016-08-02	Other	Annual General Meeting
2015-08-20	Other	Annual General Meeting
2014-09-18	Other	Annual General Meeting
2013-08-07	Other	Annual General Meeting
2011-07-07	Dividend	Dividend-Rs.10/- Per Share
2010-05-06	Dividend	Dividend-Rs.10/- Pr Share
2009-04-29	Other	Agm/Div-Rs.15/- Per Share
2008-04-11	Other	Agm/Div-Rs15 Per Share
2008-01-04	Bonus	Sch Of Agmt- Bonus Deb1:1
2007-04-25	Other	Agm Bc Start Date/Purpose Revised
2007-03-22	Other	Int Div-Rs.12/- Per Sharepurpose Revised

Price History

Date	Open	High	Low	Close	Volume
2026-06-10	8,480.00	8,546.00	8,250.00	8,288.50	8,521
2026-06-03	8,666.50	8,698.50	8,505.00	8,557.00	3,329
2026-05-27	8,826.00	8,826.00	8,357.00	8,648.00	80,279
2026-05-26	8,746.50	9,150.00	8,719.50	8,962.50	26,455
2026-05-25	8,609.00	8,895.00	8,554.00	8,800.00	9,288
2026-05-22	8,589.50	8,661.50	8,562.00	8,587.50	1,700
2026-05-21	8,708.00	8,708.00	8,574.50	8,589.50	4,397
2026-05-20	8,700.00	8,815.00	8,580.00	8,609.50	6,788
2026-05-19	8,524.50	8,736.00	8,489.50	8,695.50	5,835
2026-05-18	8,450.00	8,599.00	8,301.50	8,513.50	5,069
2026-05-15	8,405.00	8,499.00	8,316.50	8,468.50	3,064
2026-05-14	8,399.00	8,400.00	8,280.00	8,352.00	1,494
2026-05-13	8,399.50	8,439.50	8,231.50	8,376.00	5,586
2026-05-12	8,600.00	8,600.50	8,249.00	8,320.00	4,639
2026-05-11	8,493.00	8,639.50	8,400.00	8,579.50	5,307
2026-05-08	8,538.00	8,670.50	8,452.50	8,493.00	4,155
2026-05-07	8,469.00	8,575.50	8,368.50	8,549.00	9,608
2026-05-06	8,260.00	8,400.50	8,205.50	8,382.50	6,694
2026-05-05	8,010.00	8,239.50	8,010.00	8,228.00	5,451
2026-05-04	8,300.00	8,310.00	8,010.00	8,046.00	11,734
2026-04-30	8,431.50	8,465.50	8,102.00	8,213.00	11,231
2026-04-29	8,520.00	8,549.00	8,320.00	8,369.00	6,509
2026-04-28	8,578.00	8,598.50	8,426.50	8,465.50	3,122
2026-04-27	8,504.50	8,599.00	8,400.00	8,573.00	4,071
2026-04-24	8,500.00	8,594.00	8,325.50	8,500.00	6,543
2026-04-23	8,440.00	8,544.00	8,416.00	8,456.50	3,617
2026-04-22	8,452.00	8,595.50	8,422.00	8,440.00	5,217
2026-04-21	8,547.00	8,630.50	8,432.00	8,452.00	6,084
2026-04-20	8,525.00	8,598.00	8,413.00	8,531.50	4,673
2026-04-17	8,538.00	8,609.00	8,474.00	8,506.50	4,992

Frequently Asked Questions

About

AstraZeneca Pharma India Limited, listed on the National Stock Exchange of India (NSE) under the code ASTRAZEN, is a leading Indian pharmaceutical company engaged in the manufacturing, distribution, and marketing of a diverse range of pharmaceutical products. The company primarily focuses on generic and branded medicines, contributing significantly to the Indian domestic market and global pharmaceutical exports. Established in 1993, it has grown to become a key player in the sector, known for its commitment to affordable healthcare solutions.